FDA Reviews Esophageal Cancer Risk from Fosamax, Other Bone Drugs
Some oral osteoporosis drugs, known as bisphosponates, may increase the risk of esophageal cancer, according to a statement issued by the FDA.
July 22, 2011 By: Staff Writers
Some oral osteoporosis drugs, known as bisphosponates, may increase the risk of esophageal cancer, according to a statement issued by the FDA.
Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.